BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 20941510)

  • 61. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
    Kukita A; Kukita T; Nagata K; Teramachi J; Li YJ; Yoshida H; Miyamoto H; Gay S; Pessler F; Shobuike T
    Arthritis Rheum; 2011 Sep; 63(9):2744-54. PubMed ID: 21590684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Caffeine enhances osteoclast differentiation from bone marrow hematopoietic cells and reduces bone mineral density in growing rats.
    Liu SH; Chen C; Yang RS; Yen YP; Yang YT; Tsai C
    J Orthop Res; 2011 Jun; 29(6):954-60. PubMed ID: 21284030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis.
    Grcević D; Lee SK; Marusić A; Lorenzo JA
    J Immunol; 2000 Oct; 165(8):4231-8. PubMed ID: 11035056
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
    Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
    J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts.
    Yamada A; Takami M; Kawawa T; Yasuhara R; Zhao B; Mochizuki A; Miyamoto Y; Eto T; Yasuda H; Nakamichi Y; Kim N; Katagiri T; Suda T; Kamijo R
    Immunology; 2007 Apr; 120(4):573-9. PubMed ID: 17343616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
    Takahashi N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.
    Blackwell KA; Hortschansky P; Sanovic S; Choudhary S; Raisz LG; Pilbeam CC
    Prostaglandins Other Lipid Mediat; 2009 Dec; 90(3-4):76-80. PubMed ID: 19744575
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
    Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
    J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
    Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
    Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts.
    Yamaguchi M; Weitzmann MN
    Int J Mol Med; 2011 Oct; 28(4):521-5. PubMed ID: 21769418
    [TBL] [Abstract][Full Text] [Related]  

  • 72. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
    Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
    Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts.
    Ikawa Y; Yonekawa T; Ohkuni Y; Kuribayashi M; Fukino K; Ueno K
    J Toxicol Sci; 2007 Dec; 32(5):555-64. PubMed ID: 18198485
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone Morphogenetic Protein-2 Promotes Osteoclasts-mediated Osteolysis via Smad1 and p65 Signaling Pathways.
    Miao X; Yuan J; Wu J; Zheng J; Zheng W; Wang F; Wang C; Li X; Liu S; Shi Z; Li J
    Spine (Phila Pa 1976); 2021 Feb; 46(4):E234-E242. PubMed ID: 33156278
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ameloblastin and enamelin prevent osteoclast formation by suppressing RANKL expression via MAPK signaling pathway.
    Chaweewannakorn W; Ariyoshi W; Okinaga T; Morikawa K; Saeki K; Maki K; Nishihara T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):621-626. PubMed ID: 28161637
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice.
    Sheu SY; Tsai CC; Sun JS; Chen MH; Liu MH; Sun MG
    Chin Med J (Engl); 2012 Oct; 125(20):3646-53. PubMed ID: 23075718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.
    van't Hof RJ; Tuinenburg-Bol Raap AC; Nijweide PJ
    Int J Exp Pathol; 1995 Jun; 76(3):205-14. PubMed ID: 7547432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lineage-committed osteoclast precursors circulate in blood and settle down into bone.
    Muto A; Mizoguchi T; Udagawa N; Ito S; Kawahara I; Abiko Y; Arai A; Harada S; Kobayashi Y; Nakamichi Y; Penninger JM; Noguchi T; Takahashi N
    J Bone Miner Res; 2011 Dec; 26(12):2978-90. PubMed ID: 21898588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2.
    Granholm S; Henning P; Lindholm C; Lerner UH
    Bone; 2013 Jan; 52(1):83-92. PubMed ID: 23017661
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation.
    Wu X; Chim SM; Kuek V; Lim BS; Chow ST; Zhao J; Yang S; Rosen V; Tickner J; Xu J
    FEBS Lett; 2014 Jan; 588(1):143-50. PubMed ID: 24269886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.